Serum levels of RANKL and OPG, and the RANKL/OPG ratio in bisphosphonate-related osteonecrosis of the jaw: Are they useful biomarkers for the advanced stages of osteonecrosis?

BACKGROUND: We determined whether serum levels of Receptor Activator for Nuclear Factor κ B Ligand (RANKL), Osteoprotegerin (OPG), and the RANKL/OPG ratio could be useful biomarkers for the severity of oral lesions in bisphosphonate-related osteonecrosis of the jaw (BRONJ). MATERIAL AND METHODS: A c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagan, Leticia, Jiménez, Yolanda, Leopoldo, Manuel, Rubert, Andrea, Bagan, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694175/
https://www.ncbi.nlm.nih.gov/pubmed/28809381
http://dx.doi.org/10.4317/medoral.22128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694175/
https://www.ncbi.nlm.nih.gov/pubmed/28809381
http://dx.doi.org/10.4317/medoral.22128

Ejemplares similares